Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer

This study has been terminated.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Gynecologic Oncology Group
ClinicalTrials.gov Identifier:
NCT00003179
First received: November 1, 1999
Last updated: June 7, 2013
Last verified: July 2006